SYNB:NYE-Putnam Biorevolution ETF (USD)

ETF | Others |

Last Closing

USD 28.7528

Change

-0.09 (-0.32)%

Market Cap

USD 5.09M

Volume

67.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
SYNB VTI
  • VTI
Relative Returns (From:    To: 2025-03-21 )

ETFs Containing SYNB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.77% 31% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.77% 30% F 35% F
Trailing 12 Months  
Capital Gain -7.22% 13% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.22% 9% A- 22% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.08% 70% C- 55% F
Dividend Return 6.08% 66% D+ 47% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.93% 62% D 84% B
Risk Adjusted Return 76.63% 81% B- 86% B+
Market Capitalization 5.09M 9% A- 3% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.